Oskar Hagberg

Medicine and Dentistry

1. Patient 100%
2. Bladder Cancer 76%
3. Cystectomy 42%
4. Therapeutic Procedure 41%
5. Surgery 28%
6. Base 22%
7. Age 18%
8. Cumulative Incidence 16%
9. Follow up 15%
10. Gender 14%
11. Hospital 12%
12. Hazard Ratio 11%
13. Lymph Node Metastasis 10%
14. Microhematuria 9%
15. Childhood Cancer 9%
16. Diffuse Large B-Cell Lymphoma 9%
17. Association 9%
18. Overall Survival 8%
19. Comorbidity 7%
20. Bladder 7%
21. Health 7%
22. Man 6%
23. Proportional Hazards Model 6%
24. Primary Tumor 6%
25. Woman 6%
26. Lymph Node 6%
27. Mortality 6%
28. Retroperitoneal Lymph Node Dissection 6%
29. Intervention Study 6%
30. Second Cancer 6%
31. Cohort Analysis 6%
32. Urinary Diversion 5%
33. Patient Referral 5%
34. Death 5%
35. Thromboembolism 5%
36. Stricture 5%
37. Incisional Hernia 5%
38. Prognosis 5%
39. Cancer Mortality 5%
40. International Prognostic Index 5%
41. Ileal Conduit 5%